These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12209039)

  • 1. Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: a subset of myositis associated with a favourable outcome.
    Coppo P; Clauvel JP; Bengoufa D; Oksenhendler E; Lacroix C; Lassoued K
    Rheumatology (Oxford); 2002 Sep; 41(9):1040-6. PubMed ID: 12209039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies.
    Casal-Dominguez M; Pinal-Fernandez I; Corse AM; Paik J; Albayda J; Casciola-Rosen L; Johnson C; Danoff SK; Christopher-Stine L; Tiniakou E; Mammen AL
    Neurology; 2019 Mar; 92(13):e1416-e1426. PubMed ID: 30824556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical associations with autoantibody reactivities to individual components of U1 small nuclear ribonucleoprotein.
    Kaneko Y; Suwa A; Hirakata M; Ikeda Y; Kuwana M
    Lupus; 2010 Mar; 19(3):307-12. PubMed ID: 20015915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed connective tissue disease.
    Gunnarsson R; Hetlevik SO; Lilleby V; Molberg Ø
    Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):95-111. PubMed ID: 27421219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of anti-RA33 hnRNP autoantibodies and transient spread to U1-A snRNP complex of spliceosome by idiotypic manipulation with anti-RA33 antibody preparation in mice.
    Steiner G; Shovman O; Skriner K; Gilburd B; Langevitz P; Miholits M; Hoet R; Levy Y; Zandman-Goddard G; Hoefler E; Smolen JS; Shoenfeld Y
    Clin Exp Rheumatol; 2002; 20(4):517-24. PubMed ID: 12180437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease.
    Mesa A; Somarelli JA; Wu W; Martinez L; Blom MB; Greidinger EL; Herrera RJ
    Lupus; 2013 Nov; 22(13):1371-81. PubMed ID: 24158973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features and laboratory findings in children with both anti-dsDNA and anti-U1-RNP antibody].
    Miyamae T; Ito S; Machida H; Ozawa R; Higuchi R; Nakajima S; Imagawa T; Nakamura T; Mori M; Aihara Y; Ohshige K; Yokota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):405-14. PubMed ID: 18974625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-(U1) small nuclear RNA antibodies in anti-small nuclear ribonucleoprotein sera from patients with connective tissue diseases.
    van Venrooij WJ; Hoet R; Castrop J; Hageman B; Mattaj IW; van de Putte LB
    J Clin Invest; 1990 Dec; 86(6):2154-60. PubMed ID: 1701452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome.
    Lega JC; Fabien N; Reynaud Q; Durieu I; Durupt S; Dutertre M; Cordier JF; Cottin V
    Autoimmun Rev; 2014 Sep; 13(9):883-91. PubMed ID: 24704867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of anti-U1 RNA antibodies in patients with connective tissue disease. Association with HLA and clinical manifestations of disease.
    Hoffman RW; Sharp GC; Deutscher SL
    Arthritis Rheum; 1995 Dec; 38(12):1837-44. PubMed ID: 8849357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical manifestations and anti-(U1)snRNP antibodies: a prospective study of 29 anti-RNP antibody positive patients.
    Lundberg I; Nyman U; Pettersson I; Hedfors E
    Br J Rheumatol; 1992 Dec; 31(12):811-7. PubMed ID: 1458287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed Connective Tissue Disease and Epitope Spreading: An Historical Cohort Study.
    Escolà-Vergé L; Pinal-Fernandez I; Fernandez-Codina A; Callejas-Moraga EL; Espinosa J; Marin A; Labrador-Horrillo M; Selva-O'Callaghan A
    J Clin Rheumatol; 2017 Apr; 23(3):155-159. PubMed ID: 28248800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The U1 snRNP complex: an autoantigen in connective tissue diseases. An update.
    Klein Gunnewiek JM; van de Putte LB; van Venrooij WJ
    Clin Exp Rheumatol; 1997; 15(5):549-60. PubMed ID: 9307865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target.
    Fatenejad S; Brooks W; Schwartz A; Craft J
    J Immunol; 1994 Jun; 152(11):5523-31. PubMed ID: 7514640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease.
    Ghirardello A; Doria A; Vesco P; Vaccaro E; Bernardi C; Catani C; Fagiolo U; Gambari PF
    Rheumatol Int; 1996; 16(4):145-50. PubMed ID: 8961378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition?
    Lega JC; Cottin V; Fabien N; Thivolet-Béjui F; Cordier JF
    J Rheumatol; 2010 May; 37(5):1000-9. PubMed ID: 20231208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drop Head Syndrome as a Rare Complication in Mixed Connective Tissue Disease.
    Akagi M; Umeda M; Hashisako M; Hara K; Tsuji S; Endo Y; Takatani A; Shimizu T; Fukui S; Koga T; Kawashiri SY; Iwamoto N; Igawa T; Ichinose K; Tamai M; Nakamura H; Origuchi T; Niino D; Kawakami A
    Intern Med; 2020 Mar; 59(5):729-732. PubMed ID: 31735790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
    Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
    Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
    Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.